Molecular imaging in pulmonary diseases

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages 295-307

  Kashefi, Amir ^a   Kuo, Jonathan ^a   Shelton, David K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Molecular imaging; MRI; Optical imaging; PET; Pulmonary diseases; Pulmonary tumors; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 3' FLUOROTHYMIDINE F 18; CIFTIZOXIME TC 99M; CIPROFLOXACIN F 18; CIPROFLOXACIN TC 99M; DEPREOTIDE TC 99M; FIALURIDINE; FLUORINE; FLUORODEOXYGLUCOSE F 18; GADOTERIC ACID; GALLIUM 67; GALLIUM 68; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; IODINE 124; IODINE 131; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MYELOPEROXIDASE; PENTETATE TECHNETIUM TC 99M; QUANTUM DOT; RADIOPHARMACEUTICAL AGENT; SIDEROPHORE; SULESOMAB TC 99M; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TECHNEGAS; TECHNETIUM 99M; THALLIUM 201; UNCLASSIFIED DRUG;

ANTIBODY LABELING; APOPTOSIS; BIOLUMINESCENCE; CELL LABELING; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTRAST ENHANCEMENT; DEEP VEIN THROMBOSIS; DIFFUSION COEFFICIENT; ECHOGRAPHY; FIBROSING ALVEOLITIS; FLUORESCENCE ANALYSIS; HUMAN; HYPOXIA; LEUKOCYTE; LUNG ASPERGILLOSIS; LUNG CANCER; LUNG DISEASE; LUNG INFECTION; LUNG PERFUSION; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; LYMPH NODE METASTASIS; MOLECULAR IMAGING; NEAR INFRARED SPECTROSCOPY; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; TOMOGRAPHY;

ANOXIA; ANTI-BACTERIAL AGENTS; APOPTOSIS; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; LEUKOCYTES; LUNG DISEASES; MOLECULAR IMAGING; RADIOPHARMACEUTICALS; RESPIRATORY FUNCTION TESTS;

EID: 79960742591     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.6675     Document Type: Review

References (67)

1. Mochizuki T, Tsukamoto E, Kuge Y, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2001; 42:1551-1555 (Pubitemid 32953137)
2. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 2001; 1:326-333 (Pubitemid 33586613)
3. Ell P, Gambhir S. Nuclear medicine in clinical diagnosis and treatment. New York, NY: Churchill Livingstone, 2004
4. 18F] fluoro-2-deoxy-D- glucose PET. J Comput Assist Tomogr 1998; 22:601-604
5. Schuster DM, Alazraki N. Gallium and other agents in diseases of the lung. Semin Nucl Med 2002; 32:193-211 (Pubitemid 34803592)
6. Ziessman HA, O'Malley JP, Thrall JH. Nuclear medicine: the requisites. Philadelphia, PA: Mosby, 2001
7. Muzard J, Sarda-Mantel L, Layau S, et al. Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI. PLoS ONE 2009; 4:e5585
8. Helm PA, Caravan P, French BA, et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent1. Radiology 2008; 247:788-796
9. Segall GM, McDougall IR. Diagnostic value of lung uptake of indium-111 oxine-labeled white blood cells. AJR 1986; 147:601-606 (Pubitemid 16013458)
10. Love C, Tomas MB, Palestro CJ. Pulmonary activity on labelled leukocyte images: patterns of uptake and their significance. Nucl Med Commun 2002; 23:559-563 (Pubitemid 34569399)
11. Love C, Opoku-Agyemang P, Thomas MB, Pugliese PV, Bhargava KK, Palestro CJ. Pulmonary activity on labeled leukocyte images: physiologic, pathologic, and imaging correlation. Radio-Graphics 2002; 22:1385-1393
12. Chen JW, Querol Sans M, Bogdanov A, Weissleder R. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 2006; 240:473-481 (Pubitemid 44098644)
13. Ventura G, Salvatori M, Antoni M, Maiuro G, Galli G, Ortona L; International Conference on AIDS. Role of 99Tc-HIG scintigraphy in AIDS patients. Int Conf AIDS 1992; 8:B109
14. 99mTc-sulesomab in inflammation. J Nucl Med 2003; 44:11-18
15. Chen DL, Kinahan PE. Multimodality molecular imaging of the lung. J Magn Reson Imaging 2010; 32:1409-1420
16. Lai FM, Liam CK, Paramsothy M, George J. The role of 67gallium scintigraphy and high resolution computed tomography as predictors of disease activity in sputum smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 1:563-569 (Pubitemid 127509902)
17. Gualdi NC, Bayhan H, Ercan M, et al. The visualization of pulmonary tuberculosis with Tc-99m (V) DMSA and Tc-99m citrate in comparison to Ga-67 citrate. Clin Nucl Med 1995; 20:1012-1014
18. 18F-fluorodeoxyglucose uptake on positron emission tomography scan. Geriatr Gerontol Int 2010; 10:251-254
19. Win Z, Todd J, Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med 2005; 30:690-691 (Pubitemid 41361764)
20. Prvulovich EM, Miller RF, Costa DC, et al. Immunoscintigraphy with a 99Tcm-labelled antigranulocyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS. Nucl Med Commun 1995; 16:838-845
21. 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J Nucl Med 2010; 51:639-645
22. Nimmagadda S, Mangner TJ, Douglas KA, Muzik O, Shields AF. Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2′-deoxy-2′-18f-fluoro-{beta}-d- arabinofuranosyl)-5-iodouracil in normal dogs. J Nucl Med 2007; 48:655-660 (Pubitemid 47571424)
23. Bettegowda C, Foss CA, Cheong I, et al. Imaging bacterial infections with radiolabeled 1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)-5- iodouracil. Proc Natl Acad Sci USA 2005; 102:1145-1150 (Pubitemid 40170740)
24. Tjuvajev JG, Doubrovin M, Akhurst T, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 2002; 43:1072-1083 (Pubitemid 34847932)
25. Benitez A, Roca M, Martin-Comin J. Labeling of antibiotics for infection diagnosis. Q J Nucl Med Mol Imaging 2006; 50:147-152 (Pubitemid 44044027)
26. 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med 2001; 42:567-574
27. Britton KE, Vinjamuri S, Hall AV, et al. Clinical evaluation of technetium-99m infection for the localisation of bacterial infection. Eur J Nucl Med 1997; 24:553-556 (Pubitemid 27239215)
28. 99mTc-ciprofloxacin. Hepatogastroenterology 2005; 52:491-495
29. Soroa V, Velazquez E, Rabiller G, Roca M, Martin J. Infection images: behavior of ceftizoxime a 99mTc radiollabeled antitiotic. Eur J Nucl Med 2005; 32[suppl 1]:S226-P539
30. 18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging 2005; 32:143-150
31. Matsuoka S, Patz S, Albert MS, et al. Hyperpolarized gas MR imaging of the lung: current status as a research tool. J Thorac Imaging 2009; 24:181-188
32. Ohno Y, Hatabu H. Basics concepts and clinical applications of oxygen-enhanced MR imaging. Eur J Radiol 2007; 64:320-328 (Pubitemid 350116488)
33. Coxson HO, Mayo J, Lam S, Santyr G, Paggara G, Sin DD. New and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180:588-597
34. Zöphel K, Bacher-Stier C, Pinkert J, Kropp J. Ventilation/perfusion lung scintigraphy: what is still needed? A review considering technetium-99m-labeled macro-aggregates of albumin. Ann Nucl Med 2009; 23:1-16
35. Gutte H, Mortensen J, Jensen CV, et al. Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography. J Nucl Med 2009; 50:1987-1992
36. Susskind H, Weber DA, Lau YH, et al. Impaired permeability in radiation-induced lung injury detected by technetium-99m-DTPA lung clearance. J Nucl Med 1997; 38:966-971 (Pubitemid 27251995)
37. Meignan M, Rosso J, Leveau J, et al. Exercise increases the lung clearance of inhaled technetium-99m DTPA. J Nucl Med 1986; 27:274-280 (Pubitemid 17024874)
38. Chopra SK, Taplin GV, Tashkin DP, Elam D. Lung clearance of soluble radioaerosols of different molecular weights in systemic sclerosis. Thorax 1979; 34:63-67 (Pubitemid 9138534)
39. 99mTc-DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease. J Nucl Med 2010; 51:735-741
40. Morris TA. SPECT imaging of pulmonary emboli with radiolabeled thrombus-specific imaging agents. Semin Nucl Med 2010; 40:474-479
41. Macfarlane D, Socrates A, Eisenberg P, et al. Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab fragment (99m Tc-DI-DD3B6/22-80B3): results of a phase I trial. Eur J Nucl Med Mol Imaging 2009; 36:250-259
42. Coleman RE. Pet in lung cancer. J Nucl Med 1999; 40:814-820 (Pubitemid 29210758)
43. Branca RT, Cleveland CI, Eisenberg P, et al. Molecular MRI for sensitive and specific detection of lung metastases. Proc Natl Acad Sci USA 2010; 107:3693-3697
44. Shankar LK, Sullivan DC. Functional imaging in lung cancer. J Clin Oncol 2005; 23:3203-3211 (Pubitemid 46211344)
45. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 2009; 50:1820-1827
46. Divgi CR. Molecular imaging of pulmonary cancer and inflammation. Proc Am Thorac Soc 2009; 6:464-468
47. Kagna O, Solomonov A, Keidar Z, et al. The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer. Eur J Nucl Med Mol Imaging 2009; 36:997-1004
48. Chen DL, Dehdashti F. Advances in positron emission tomographic imaging of lung cancer. Proc Am Thorac Soc 2005; 2:541-544 (Pubitemid 43128027)
49. 18F-fluorodeoxyglucose-positron emission tomography. Chest 2006; 129:393-401
50. 11C-l-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 2007; 10:1-18
51. 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med 2000; 41:283-290
52. Hicks RJ. PET for therapeutic response monitoring in oncology. PET Clin 2008; 3:89-99
53. Wong TZ, Lacy JL, Petry NA, et al. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator. AJR 2008; 190:427-432
54. 18F-fluoromisonidazole. Semin Nucl Med 2007; 37:451-461
55. 18F-FDG in lung cancer. J Nucl Med 2009; 50:1948-1953
56. Blankenberg FG. Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V. Proc Am Thorac Soc 2009; 6:469-476
57. 18F-FDG dual-head coincidence imaging. J Nucl Med 2007; 48:1442-1448
58. Shih WJ, Hirschowitz E, Bensadoun E, Woodring J, Ryo YU, Kraman S. Biodistribution on Tc-99m labeled somatostatin receptor-binding peptide (Depreotide, NeoTec) planar and SPECT studies. Ann Nucl Med 2002; 16:213-219 (Pubitemid 34717573)
59. 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2005; 32:1026-1032
60. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999; 340:858-868 (Pubitemid 29142631)
61. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79:813-829 (Pubitemid 27076348)
62. Komori T, Narabayshi I, Matsui R, et al. Evaluation of uptake and release of technetium-99m MIBI SPECT of pulmonary and mediastinal lesions. Ann Nucl Med 1997; 11:227-232 (Pubitemid 27414970)
63. Ntziachristos V. Optical imaging of molecular signatures in pulmonary inflammation. Proc Am Thorac Soc 2009; 6:416-418
64. 99mTc- MIBI SPET. Eur J Nucl Med Mol Imaging 2004; 31:13-21
65. Schuster DP, Kovacs A, Garbow J, Piwnica-Worms D. Recent advances in imaging the lungs of intact small animals. Am J Respir Cell Mol Biol 2004; 30:129-138 (Pubitemid 38152965)
66. Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 2003; 13:231-243 (Pubitemid 36798598)
67. Ciarlo M, Russo P, Cesario A, et al. Use of the semiconductor nanotechnologies "quantum dots" for in vivo cancer imaging. Recent Pat Anticancer Drug Discov 2009; 4:207-215